Sign in

CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company

Equillium, Inc.

Sign in to watch
Ticker
EQ
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821554746
Phone
(858) 412-5302
Business address
2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
  1. 4 Planned sale Sr. Vice President and COO sold 14,584 shares at $2.93 ($42,737)
  2. 4 Open-market sale President and CSO sold 230,975 shares at an average $3.13 ($723,830)
  3. 4 Planned sale Principal Accounting Officer sold 65,000 shares at $2.95 ($191,750)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale Sr. Vice President and COO sold 95,833 shares at an average $2.79 ($267,209)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale Sr. Vice President and COO sold 120,312 shares at $2.50 ($300,816)
  11. 4/A Planned sale Sr. Vice President and COO sold 185,937 shares at an average $1.76 ($328,104)
  12. 4 Planned sale Sr. Vice President and COO sold 181,219 shares at $2.00 ($362,438)
  13. 4 Planned sale Sr. Vice President and COO sold 185,937 shares at an average $1.76 ($328,104)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Planned sale Principal Accounting Officer sold 6,533 shares at $1.29 ($8,428)
  18. 4 Planned sale Sr. Vice President and COO sold 100,000 shares at $1.50 ($150,000)
  19. 4 Planned sale Sr. Vice President and COO sold 35,704 shares at an average $1.33 ($47,486)
  20. 4 Planned sale Sr. Vice President and COO sold 8,098 shares at an average $0.95 ($7,696)

Page 1 of 9 · 177 filings